Structural Heart Disease Specialists are experts in diagnosing and treating disorders related to the heart’s physical structures, including valves, septa, and chambers. These conditions may be congenital or develop over time, causing complications like valve stenosis, regurgitation, or septal defects that impair blood flow and heart function. Utilizing advanced imaging modalities such as 3D echocardiography, cardiac CT, and MRI, these specialists provide precise assessments to guide treatment decisions. Their approach often includes catheter-based interventions like transcatheter valve repair or replacement, which offer less invasive alternatives to surgery and quicker recovery times for patients.
These specialists work within multidisciplinary teams alongside cardiologists, cardiac surgeons, and imaging experts to create personalized treatment plans. Their expertise is critical in clinical trials that test innovative devices and techniques, helping to expand therapeutic options for patients with complex structural heart diseases. Through ongoing research and education, they contribute to evolving guidelines and best practices worldwide. By focusing on early diagnosis, minimally invasive therapies, and comprehensive care, structural heart disease specialists significantly improve patient outcomes, reduce hospital stays, and enhance quality of life for those affected by these challenging conditions. Their dedication continues to push the boundaries of cardiac care, ensuring patients benefit from the latest medical advances.
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of Life, the skinny on statins and beyond !
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Study of pathological cardiac hypertrophy regression
Shuping Zhong, University of Southern California, United States
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Atypical takotsubo cardiomyopathy presenting as st-elevation myocardial infarction
Sana Tariq, Manchester University NHS Foundation Trust, United Kingdom